The store will not work correctly when cookies are disabled.
The page will load shortly, Thanks for your patience!
| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source |
| 1. | ALA3428359 | B | Inhibition of human CD38 extracellular domain expressed in Pichia pastoris assessed as NAD hydrolysis by colorimetric-based assay | Homo sapiens | 84 | ALA3425493 | assay format | Scientific Literature |
| 2. | ALA3428360 | B | Inhibition of mouse recombinant CD38 extracellular domain expressed in CHO CGE cells assessed as NAD hydrolysis by fluorescence plate reader analysis | Mus musculus | 84 | ALA3425493 | cell-based format | Scientific Literature |
| 3. | ALA3428361 | B | Inhibition of wild type fully glycosylated human recombinant CD38-catalyzed NAD hydrolysis | Homo sapiens | 4 | ALA3425493 | single protein format | Scientific Literature |
| 4. | ALA3428362 | A | Permeability across MDCK cells | Canis lupus familiaris | 11 | ALA3425493 | cell-based format | Scientific Literature |
| 5. | ALA3428363 | P | Solubility of the compound by chemiluminescent nitrogen detection method | | 12 | ALA3425493 | small-molecule physicochemical format | Scientific Literature |
| 6. | ALA3428364 | A | Clearance in mouse at 1 mg/kg, iv using 10% DMSO:10% PEG400:80% (20% SBE-CD, citrate buffered pH 6.0) as formulation | Mus musculus | 2 | ALA3425493 | organism-based format | Scientific Literature |
| 7. | ALA3428366 | A | Volume of distribution at steady state in mouse at 1 mg/kg, iv using 10% DMSO:10% PEG400:80% (20% SBE-CD, citrate buffered pH 6.0) as formulation | Mus musculus | 2 | ALA3425493 | organism-based format | Scientific Literature |
| 8. | ALA3428369 | A | Terminal half life in mouse at 10 mg/kg, po | Mus musculus | 1 | ALA3425493 | organism-based format | Scientific Literature |
| 9. | ALA3428370 | A | Terminal half life in mouse at 1 mg/kg, iv using 10% DMSO:10% PEG400:80% (20% SBE-CD, citrate buffered pH 6.0) as formulation | Mus musculus | 2 | ALA3425493 | organism-based format | Scientific Literature |
| 10. | ALA3428373 | A | Oral bioavailability in mouse at 10 mg/kg | Mus musculus | 1 | ALA3425493 | organism-based format | Scientific Literature |
| 11. | ALA3428375 | A | Cmax in mouse at 10 mg/kg, po | Mus musculus | 1 | ALA3425493 | organism-based format | Scientific Literature |
| 12. | ALA3428890 | A | Cmax in mouse at 1 mg/kg, iv using 10% DMSO:10% PEG400:80% (20% SBE-CD, citrate buffered pH 6.0) as formulation | Mus musculus | 2 | ALA3425493 | organism-based format | Scientific Literature |
| 13. | ALA3428893 | A | Dose normalized AUC in mouse at 10 mg/kg, po | Mus musculus | 1 | ALA3425493 | organism-based format | Scientific Literature |
| 14. | ALA3428894 | A | Dose normalized AUC in mouse at 1 mg/kg, iv using 10% DMSO:10% PEG400:80% (20% SBE-CD, citrate buffered pH 6.0) as formulation | Mus musculus | 2 | ALA3425493 | organism-based format | Scientific Literature |
| 15. | ALA3429030 | P | Retention time of the compound by RP-HPLC analysis | | 25 | ALA3425493 | small-molecule physicochemical format | Scientific Literature |